Skip to main content
. 2021 Feb 12;100(6):e24182. doi: 10.1097/MD.0000000000024182

Table 2.

Outcome comparisons between hydronephrosis group and non-hydronephrosis group in patients with cervical cancer.

Non-hydronephrosis (n = 1780) hydronephrosis (n = 445) Crude HR Adjust HR
Outcomes Events PY IR Events PY IR (95% CI) (95% CI)
All-cause mortality 104 11806 8.81 79 2185 36.16 3.96 (2.95–5.31)∗∗∗ 3.05 (2.24–4.15)∗∗∗
Urethral catheter 164 11507 14.25 113 2069 54.62 4.86 (3.53–6.69)∗∗∗ 3.87 (2.77–5.41)∗∗∗
CKD 152 11462 13.26 125 1870 66.84 4.73 (3.73–6.00)∗∗∗ 2.60 (2.02–3.33)∗∗∗
Removal of DJ 61 11587 5.26 70 1919 36.48 3.16 (2.23–4.48)∗∗∗ 2.94 (2.01–4.29)∗∗∗
Referred for PCN 7 11775 0.59 102 1927 52.93 33.78 (15.57–73.30)∗∗∗ 33.06 (14.81–73.77)∗∗∗
Keep DJ 7 11768 0.59 133 1642 81.00 31.42 (14.61–67.58)∗∗∗ 30.36 (13.89–66.36)∗∗∗
Infection 384 9793 39.21 116 1568 73.98 1.14 (0.92–1.40) 1.22 (0.98–1.51)
Urinary stones 92 11347 8.11 95 1671 56.85 1.98 (1.48–2.65)∗∗∗ 1.901.41–2.56)∗∗∗
Diversion 11 11758 0.94 1 2185 0.46 0.62 (0.08–5.97) 0.71 (0.04–10.51)
Nephrectomy 52 11568 4.50 15 2101 7.14 2.02 (1.13–3.59)∗∗∗ 2.03 (1.09–3.76)∗∗∗

HR adjusted for age, gender, diabetes mellitus, hypertension, chronic kidney disease (CKD).

CI = confidence interval, HR = hazard ratio, IR = incidence rate, per 1000 person-years, PCN = percutaneous nephrostomy, PY = person-years.

P < .05.

∗∗

P < .01.

∗∗∗

P < .001.